OIG Hospice Audits: The Findings Behind the Dollar Figure

OIG hospice audit findings include unsupported care levels, missing terminal-illness certifications and duplicate Medicare payments. For a nurse, biller or medical director, the revealing part is the gap between the patient they knew and the patient described in the file. A hospice fraud case follows that gap into the decisions behind the claim: who supplied the clinical information, who questioned it and why billing continued.

What OIG Hospice Audit Findings Reveal

OIG hospice audit findings show hospices billing for care levels patients did not need and submitting claims without required certifications or clinical documentation. The Department of Health and Human Services’ Office of Inspector General brought those findings together in its July 2018 hospice portfolio.

Those findings lead back to different parts of the operation: admissions, physician review, nursing documentation and billing. An insider may know exactly where the record stopped matching the care.

Medicare contractors also review claims. In its response to the portfolio, the Centers for Medicare & Medicaid Services described contractor reviews of lengthy general inpatient stays before payment and recovery of overpayments found through those reviews.

What Are the Criteria for a GIP Hospice?

General inpatient hospice care is for pain control or symptom management that cannot be managed in another setting. It is intended for short-term use. The patient’s symptoms and the care needed to control them support the higher payment.

The distinction is visible in an example OIG included in its portfolio. A beneficiary in Florida entered general inpatient care for symptom management. Her symptoms were managed within two days, but the hospice continued that level of care for fifteen additional days. Taxpayers kept paying for crisis care after the crisis had ended.

OIG also found hospices billing general inpatient care when patients needed routine care, or when a caregiver’s absence called for inpatient respite. The setting alone could not explain the bill. The clinical need had to support the level charged.

Hospice billing fraud allegations involving continuous home care led to Odyssey HealthCare’s $25 million settlement in 2012. The Justice Department alleged that the company billed for care that was unnecessary or failed to meet Medicare requirements. Continuous home care concerns crisis care needed to keep a patient at home. The same underlying comparison matters: the patient’s condition, the services delivered and the level on the claim.

What the General Inpatient Care Sample Showed

OIG found stays where the beneficiary never needed general inpatient care and stays where that level was needed for only part of the period. The reason for admission and the reason for continuing the expensive level may tell different stories.

OIG’s March 2016 general inpatient care study used medical-record reviews of a stratified random sample of 565 stays from 2012. The study projected $268.1 million in inappropriate payments, representing 26% of payments for that care level.

Ineligible Patients Versus Missing Documentation

In a hospice OIG audit, ineligible versus missing documentation describes different reasons for questioning payment. Clinical eligibility concerns the patient’s condition and prognosis. Missing documentation concerns the evidence available to support a required certification, election or service.

Medicare hospice eligibility rests on a physician’s certification of a life expectancy of six months or less if the illness runs its normal course. A certification also carries documentation requirements. OIG’s portfolio reported that, in 14% of general inpatient stays in 2012, the certifying physician failed to meet at least one requirement, such as explaining the clinical findings or attesting to the examination or record review behind them.

An election statement answers another question: what benefit the patient chose and understood. OIG found statements that omitted required information about the benefits being waived or the palliative nature of hospice. That finding concerns the patient’s choice and the hospice’s explanation of it. A terminal prognosis addresses the clinical basis for care.

The general inpatient study also identified stays with no evidence of a hospice election or a terminal-illness certification. To understand the conduct behind it, the useful questions concern who prepared the paperwork, what the physician actually reviewed and what happened when someone raised the omission.

Different errors can appear in the same file. A missing election form and an unsupported physician narrative can concern the same patient.

Why Long Stays and Sparse Visits Attract Attention

Medicare’s daily hospice payment creates a reason to examine long stays alongside the care delivered. Hospice costs tend to be higher around admission and death, with less intensive care in between. The payment continues through that middle period.

The Inspector General’s 2015 assisted-living study found a median hospice stay of 98 days for beneficiaries receiving care in 2012 whose primary setting was assisted living. It also found an average of 4.8 hours of hospice visits per week for beneficiaries receiving routine care there. The report stated the payment incentive plainly:

For an insider, the connection worth explaining is how the business responded when a patient’s needs changed: whether the plan changed, whether visits followed it and what the physician was told.

Payment design also shapes decisions about how much care to provide. Quality, Reputation, and Reimbursement Design in the Hospice Industry, a 2026 working paper from Kansas State University, modeled competition among California hospices using visits as its quality measure. Its model predicted that lower daily reimbursement would reduce quality, while a payment combining days and visits could reduce spending while preserving quality.

The Government Accountability Office’s June 2026 examination of routine home care compared actual daily payments with what comparable visits would have cost at home-health visit rates. For its selected beneficiaries and hospices, Medicare effectively paid low-visit hospices twice as much per visit as high-visit hospices, on average.

What Is the 80/20 Rule in Hospice?

The hospice 80/20 rule limits inpatient days across a provider’s Medicare hospice business. When inpatient days exceed 20% of total hospice days, payment for the excess inpatient days is reduced to the routine home care rate. The calculation concerns the provider’s mix of days.

The aggregate cap measures something else: total annual Medicare hospice payments against a ceiling based on a per-beneficiary amount and the beneficiaries served. Its calculation includes beneficiary shares across hospices and cap years. The payment rules therefore create separate questions about the level billed on a patient’s claim, the provider’s inpatient share and its annual payment ceiling.

When Medicare Pays Twice for Hospice Drugs

Hospice payment includes drugs used primarily for relief of pain and symptom control related to the terminal illness. When Part D pays separately for those drugs, Medicare pays twice. The pharmacy payment and the hospice payment belong in the same review even though they arrive through different parts of Medicare.

Clinical Review and Civil Whistleblower Cases

Civil whistleblower cases examine how the certification was made and what the provider knew. In AseraCare’s 2019 decision, the court said evidence that a physician used information known to be false or signed without exercising clinical judgment mattered to whether the claims were false.

In Care Alternatives in 2020, the court allowed an expert’s review of the charts to challenge whether the certifications had a reasonable clinical basis. For a hospice insider, the patient notes and the information given to the physician connect the clinical decision to the bill.

What the Insider Adds to the Audit

An insider can explain how the disputed record was made and what happened after someone questioned it. What management did with an internal audit can be as revealing as the original chart review. In the Guardian Hospice case, the whistleblowers described internal reviews finding missing election forms, inadequate certification narratives and missing face-to-face documentation in the same patient files. Their complaint then alleged a response to the documentation problem:

The alleged instruction connects the missing record to a decision about what the file should say afterward. The Justice Department announced a $3 million settlement in October 2015 over allegations that Guardian billed for patients it knew were not terminally ill, alongside failures of training and oversight.

For hospice fraud whistleblowers, the clinical notes, internal review and management response can connect the patient to the payment. A whistleblower case under the False Claims Act can pay 15% to 30% of what the government recovers.

When You Know Why the Chart Changed

If you saw clinical objections buried, records rewritten or billing continue after an internal review, tell our whistleblower experts what happened inside the hospice. We help you build your strongest hospice whistleblower case and bring in healthcare fraud whistleblower lawyers who understand clinical certification and Medicare billing. We stay beside you as the patient records, audit findings and management decisions become the case.